Kohjin Bio Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3283630006
JPY
1,600.00
198 (14.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Net Sales
5,206.29
4,770.10
4,742.99
3,947.09
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
5,206.29
4,770.10
4,742.99
3,947.09
Raw Material Cost
2,840.25
2,888.80
2,288.81
1,907.89
Purchase of Finished goods
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
30.07
22.87
32.47
38.94
Selling and Distribution Expenses
1,206.07
1,043.87
1,025.69
934.97
Other Expenses
13.88
21.77
12.85
9.57
Total Expenditure (Excl Depreciation)
4,215.15
4,173.27
3,475.50
2,977.51
Operating Profit (PBDIT) excl Other Income
991.1
596.8
1267.5
969.5999999999999
Other Income
105.41
61.65
9.31
-11.76
Operating Profit (PBDIT)
1,457.52
958.10
1,444.39
1,136.88
Interest
30.07
22.87
32.47
38.94
Exceptional Items
-51.17
0.00
0.00
3.19
Gross Profit (PBDT)
2,366.04
1,881.30
2,454.18
2,039.20
Depreciation
360.97
299.63
167.59
179.06
Profit Before Tax
1,015.30
635.60
1,244.34
922.06
Tax
220.54
250.62
414.55
334.39
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
794.76
384.98
829.79
587.67
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
794.76
384.98
829.79
587.67
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
794.76
384.98
829.79
587.67
Equity Capital
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
Reserves
5,781.82
3,342.39
3,017.83
2,216.89
Earnings per share (EPS)
157.56
76.77
165.46
117.18
Diluted Earnings per share
157.56
76.77
165.46
117.18
Operating Profit Margin (Excl OI)
19.04%
12.51%
26.72%
24.56%
Gross Profit Margin
26.43%
19.61%
29.77%
27.9%
PAT Margin
15.27%
8.07%
17.5%
14.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 9.14% vs 0.57% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 106.44% vs -53.60% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 50.82% vs -37.53% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 31.44% vs -29.54% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Kohjin Bio Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
5,206.29
0
5,206.29
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,206.29
0
5,206.29
Raw Material Cost
2,840.25
0
2,840.25
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
30.07
0
30.07
Selling and Distribution Expenses
1,206.07
0
1,206.07
Other Expenses
13.88
0.00
13.88
Total Expenditure (Excl Depreciation)
4,215.15
0
4,215.15
Operating Profit (PBDIT) excl Other Income
991.14
0.00
991.14
Other Income
105.41
0
105.41
Operating Profit (PBDIT)
1,457.52
0
1,457.52
Interest
30.07
0
30.07
Exceptional Items
-51.17
0
-51.17
Gross Profit (PBDT)
2,366.04
0
2,366.04
Depreciation
360.97
0
360.97
Profit Before Tax
1,015.30
0
1,015.30
Tax
220.54
0
220.54
Provisions and contingencies
0
0
0.00
Profit After Tax
794.76
0
794.76
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
794.76
0
794.76
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
794.76
0
794.76
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
5,781.82
0
5,781.82
Earnings per share (EPS)
157.56
0
157.56
Diluted Earnings per share
157.56
0
157.56
Operating Profit Margin (Excl OI)
19.04%
0%
0.00
19.04%
Gross Profit Margin
26.43%
0%
0.00
26.43%
PAT Margin
15.27%
0%
0.00
15.27%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 520.63 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 9.14% vs 0.57% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 79.48 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 106.44% vs -53.60% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 135.21 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 50.82% vs -37.53% in Mar 2024

Annual - Interest
Interest 3.01 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 31.44% vs -29.54% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.04%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024